(Q38461685)

3 September 2017

title

Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women (English)

1 reference

3 September 2017

0 references

Clarke CA

1

1 reference

3 September 2017

Glaser SL

2

1 reference

3 September 2017

Dorfman RF

3

1 reference

3 September 2017

Mann R

4

1 reference

3 September 2017

DiGiuseppe JA

5

1 reference

3 September 2017

Prehn AW

6

1 reference

3 September 2017

Ambinder RF

7

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

3 September 2017

1 reference

3 September 2017

volume

91

1 reference

3 September 2017

issue

8

1 reference

3 September 2017

page(s)

1579-1587

1 reference

Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Incidence of second cancers in patients treated for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Prognostic significance of Epstein-Barr virus association in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Influence of Epstein-Barr virus genomes on patient survival in Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Variability in interpretation of immunohistologic findings in lymphoproliferative disorders by hematopathologists. A comprehensive statistical analysis of interobserver performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Classification of Hodgkin's disease biopsies by a panel of four histopathologists. Report of 1,140 patients from the German National Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Survival of the older patient compared with the younger patient with Hodgkin's disease. Influence of histologic type, staging, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

The epidemiology of Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

Prognostic factors in advanced Hodgkin's disease--can they guide therapeutic decisions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010415%2991%3A8%3C1579%3A%3AAID-CNCR1169%3E3.0.CO%3B2-L

10.1002/1097-0142(20010415)91:8<1579::AID-CNCR1169>3.0.CO;2-L

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference